Ulixacaltamide is an investigational new drug developed by Praxis Precision Medicines, designed to treat essential tremor, a common neurological disorder characterized by involuntary rhythmic shaking. From Wikipedia
The peer-reviewed mouse study identifies the reticular thalamic nucleus as a potential treatment target, with translation to patients uncertain.
